RE:RE:NEWS - New Contractlscfa wrote: clinical trials are short term and cancer patients expire so how real is it to suggest this is recurring revenue.
Does Iscfa understand that clinical trials last for years?
Phase 1, Phase 2, Phase 3.
Each phase requires more patients, across many clinics, in multiple cities. Anyone having owned pre- revenue drug companies know how long and intense these trials can be.
Oh, and many, many cancer patients live for years. Chemotherapy, radiation, and recovery from surgery.
Which means being monitored daily. Ever know a loved one who is on chemo?? There are literally a dizzying amount of side effects from these drugs.
Long Reliq!